Compliance recovery of vaginal normocenosis
https://doi.org/10.21518/2079-701X-2018-7-112-115
Abstract
The article presents the current data on bacterial vaginosis, issues of epidemiology, clinical manifestations and treatment using oral probiotic.
About the Authors
A. L. Tikhomirov
A.I.Yevdokimov Moscow State University of Medicine and Dentistry
Russian Federation
MD, Prof.
Russian Federation
MD, Prof.
I. B. Manukhin
A.I.Yevdokimov Moscow State University of Medicine and Dentistry
Russian Federation
MD, Prof.
Russian Federation
MD, Prof.
V. V. Kazenashev
A.I.Yevdokimov Moscow State University of Medicine and Dentistry
Russian Federation
PhD in medicine
Russian Federation
PhD in medicine
E. I. Manukhina
A.I.Yevdokimov Moscow State University of Medicine and Dentistry
Russian Federation
MD, Prof.
Russian Federation
MD, Prof.
A. N. Krizhanovskaya
Maternity Hospital No. 8, Moscow
Russian Federation
PhD in medicine
Russian Federation
PhD in medicine
References
1. Tikhomirov AL, Oleinik ChG. Bacterial vaginosis: some aspects of etiology, pathogenesis, clinic, diagnosis and treatment. Gynekologiya, 2004, 6 (2): 62-65.
2. Sobel JD. Vaginitis. N Engl J Med, 1997, 337: 1896-1903.
3. Кира Е.Ф. Бактериальный вагиноз. М: МИА, 2012. 472 с.
4. Sobel JD. Vulvovaginal candidosis. Lancet, 2007, 369: 1961-1971.
5. Donders G. Diagnosis and management of bacterial vaginosis and other types of abnormal vaginal bacterial flora: review. Obstet Gynecol Surv, 2010, 65: 462-473.
6. Sobel JD. Bacterial vaginosis. Annu Rev Med, 2000, 51: 349-356.
7. Weir E. Bacterial vaginosis: morequestions than answers. CMAJ, 2004, 171: 448.
8. Clinical guidelines. Obstetrics and gynecology. 4th edition, revised and supplemented. Edited by Savelyeva GM, Serova VN, Sukhikh GT. M.: GEOTAR-MEDIA, 2015. 1024 p.
9. Koumans EH, Sternberg M, Bruce C et al. The prevalence of bacterial vaginosis in the United States, 2001-2004: associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis, 2007, 34: 864–869.
10. Donders G. Diagnosis and Manadgement of bacterial vaginosis and other types of abnormal bacterial flora: a review. Obstet Gynecol Surv, 2010, 65(7): 462-473.
11. Bautista CT, Wurapa E, Sateren WB et al. Bacterial vaginosis: a 4. synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infections. Mil Med Res, 2016, 3: 4.
12. Laxmi U, Agrawal S, Raghunandan C et al. Association of bacterial vaginosis with adverse fetomaternal outcome in women with spontaneous preterm labor: a prospective cohort study. J Matern Fetal Neonatal Med, 2012, 25: 64–67.
13. Goldenberg RL, Klebanoff MA, Bacterial colonization of the vagina during pregnancy in four ethnic groups. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol, 1996 May, 174(5): 1618-1621.
14. Pastore LM, Royce RA et.al. Association between bacterial vaginosis and fetal fibronectin at 24-29 weeks’ gestation. Obstet Gynecol, 1999 Jan, 93(1): 117-123.
15. Obstetrics: national guidelines. Edited by Savelyeva GM, Sukhykh GT, Serova VN, Radzinsky VE. 2nd edition, revised and supplemented M.: GEOTAR-MEDIA, 2015. 1080 p.
16. Radzinsky VE, Ordiants IM. BIOS Study: comparative assessment of different treatment regimens for bacterial vaginosis and non-specific vulva vaginitis. Status Praesens, 2013, 1 (12): 52-55.
17. Savicheva AM, et al. A comparative, controlled, randomized study of the efficacy of a two-stage treatment for bacterial vaginosis. Gynekologiya, 2013, 15 (5): 32-35.
18. Reid G, Bocking A. The potential for probiotics to prevent bacterial vaginosis and preterm labor. Am J Obstet Gynecol, 2003, 189: 1202–1208.
19. Radzinsky VE, Ordiyants IM. Two-stage therapy for vaginal infections. M.: Status Praesens. 2012, 16 p.
20. Cianci A, Giordano R, Della A et al. Efficasy of Lactobacillus Rhamnosus GR-1 and of Lactobacillus Reuteri RC-14 in the treatment and prevention of vaginoses and bacterial vaginitis relapses. Minerva Ginecol, 2008, 60(5): 369-376.
21. Marelli G, Papaleo E, Ferrari A. Lactobacilli for prevention of urogenital infections: a review. Eur Rev Med Pharmacol Sci, 2004, 8(2): 87-95.
22. Reid G et al. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol, 2001, 30(1): 49-52.
23. Gardiner GE et al. Oral administration of the probiotics combination Lactobacillus Rhamnosus GR-1 and of Lactobacillus Reuteri RC-14 for human intestinal applications. International Dairy Journal, 2002, 12(2-3): 191-196.
24. Reid G et al. Oral use of Lactobacillus Rhamnosus GR-1 and of Lactobacillus Reuteri RC-14 significantly alters vaginal flora: rand-omized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol, 2003, 3(2): 131-134.
25. Vujic G. Efficasy of oral applied probiotic capsules for bacterial vaginosis and other vaginal infections: a double-blind, randomized, placebo-controlled study Goran. Eur J Obstet Gynecol Reprod Biol, 2013, 168(10): 75-79.
Review
For citations:
Tikhomirov AL, Manukhin IB, Kazenashev VV, Manukhina EI, Krizhanovskaya AN. Compliance recovery of vaginal normocenosis. Meditsinskiy sovet = Medical Council. 2018;(7):112-115. (In Russ.) https://doi.org/10.21518/2079-701X-2018-7-112-115
Views:
655
Email this article 